Figure 6. NLC protect CLL cells from apoptosis by contact through LFA-3.
Percentage viability of CLL cells after 7 days of culture either alone or in the presence of NLC, treated or not (UT) with an isotype control (ctrl Ab) or with a blocking antibody: anti-LFA-3 (A), anti-ICAM-1 (B) or anti-CD31 (C) (8 independent experiments: 8 CLL patients).